1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296
1990.90 -13.50 (-0.67%)
512.6K
NSE+BSE Volume

NSE 04 Sep, 2025 3:31 PM (IST)

Product Launch
Glenmark to launch bioequivalent of Eisai's Halaven injection in US, with annual sales of $66.3 mn See details


Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

571 Votes:
Buy 79.33%
Sell 13.66%
Hold 7.01%
BUY
SELL
HOLD